0001214659-23-013096.txt : 20231003 0001214659-23-013096.hdr.sgml : 20231003 20231003170542 ACCESSION NUMBER: 0001214659-23-013096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Caroline CENTRAL INDEX KEY: 0001684087 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231305162 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-62746.xml PRIMARY DOCUMENT X0508 4 2023-09-05 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001684087 Young Caroline 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203 true false false false 1 Common Stock 2023-09-05 5 L false E 65 1.68 A 21399 D Common Stock 2023-09-06 5 L false E 65 1.65 A 21464 D Common Stock 2023-09-07 5 L false E 65 1.68 A 21529 D Common Stock 2023-09-08 5 L false E 65 1.68 A 21594 D Common Stock 2023-09-11 5 L false E 65 1.71 A 21659 D Common Stock 2023-09-12 5 L false E 65 1.76 A 21724 D Common Stock 2023-09-13 5 L false E 65 1.83 A 21789 D Common Stock 2023-09-14 5 L false E 65 1.84 A 21854 D Common Stock 2023-09-15 5 L false E 23 1.82 A 21877 D Common Stock 2023-09-18 5 L false E 55 2.03 A 21932 D Common Stock 2023-09-19 5 L false E 55 2.12 A 21987 D Common Stock 2023-09-20 5 L false E 55 2.14 A 22042 D Common Stock 2023-09-21 5 L false E 55 2.28 A 22097 D Common Stock 2023-09-22 5 L false E 55 2.29 A 22152 D Common Stock 2023-09-25 5 L false E 55 2.24 A 22207 D Common Stock 2023-09-26 5 L false E 55 2.07 A 22262 D Common Stock 2023-09-27 5 L false E 55 1.98 A 22317 D Common Stock 2023-09-28 5 L false E 55 1.96 A 22372 D Common Stock 2023-09-29 5 L false E 55 1.90 A 22427 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Caroline Young by /s/ John Hamm as attorney-in-fact 2023-10-03